Biological functions of the m6A reader YTHDF2 and its role in central nervous system disorders

2024/10/16 by Lili Song, Huimin Liu, Hui Li +5 · 8 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #RNA modifications and cancer #Cardiac Structural Anomalies and Repair #Peptidase Inhibition and Analysis

paper · doi:10.1016/j.bcp.2024.116576

Citations

• Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

Cited by

• METTL3‑mediated m6A methylation and its impact on OTUD1 expression in chronic obstructive pulmonary disease. [europepmc]
• Novel insights into the N 6-methyladenosine modification on circRNA in cancer. [europepmc]
• The role of N6-methyladenosine (m 6 A) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential. [europepmc]
• FTO enhances OSCC progression via m⁶A-dependent stabilization of PKM2 mRNA through YTHDF2 modulation. [europepmc]
• A role for the cholinergic neuron circadian clock in RNA metabolism and mediating neurodegeneration. [europepmc]
• YTHDF2 in inflammation: Mechanisms and therapeutic strategies. [europepmc]
• Double-edged role of N6-methyladenosine reader YTH structural domain family protein 2 in neurological disorders: Molecular mechanisms and translational prospects. [europepmc]
• m6A RNA methylation in neural plasticity, brain aging, and neurodegenerative vulnerability. [europepmc]